(Q54379487)

29 May 2018

title

A novel IKKα inhibitor, noraristeromycin, blocks the chronic inflammation associated with collagen-induced arthritis in mice. (English)

1 reference

29 May 2018

0 references

Masumi Ito

1

1 reference

29 May 2018

Takaichi Hamano

2

1 reference

29 May 2018

Takao Komatsu

3

1 reference

29 May 2018

Kaori Asamitsu

4

1 reference

29 May 2018

Tomio Yamakawa

5

1 reference

29 May 2018

Takashi Okamoto

6

1 reference

29 May 2018

publication date

5 February 2014

1 reference

29 May 2018

published in

Modern Rheumatology

1 reference

29 May 2018

volume

24

1 reference

29 May 2018

issue

5

1 reference

29 May 2018

page(s)

775-780

1 reference

29 May 2018

NF-kappa B: ten years after

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

NF-kappa B signaling and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Integrating cell-signalling pathways with NF-kappaB and IKK function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

New regulators of NF-kappaB in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Non-canonical NF-κB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Beyond NF-κB activation: nuclear functions of IκB kinase α

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Intra-articular nuclear factor-κB blockade ameliorates collagen-induced arthritis in mice by eliciting regulatory T cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

The IKK NF-kappa B system: a treasure trove for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Discovery of novel and selective IKK-beta serine-threonine protein kinase inhibitors. Part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Aberrant MHC class II expression in mouse joints leads to arthritis with extraarticular manifestations similar to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Tumor necrosis factor and anti-tumor necrosis factor therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2013.879416

10.3109/14397595.2013.879416

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018